【摘要】 目的　观察亚砷酸注射液治疗中晚期原发性肝癌近期疗效及不良反应。方法　 2 0 0 1 - 0 2～ 2 0 0 1 - 1 0对 1 0例中晚期原发性肝癌 ,采用亚砷酸注射单药静脉滴注 2 8d。结果　生存质量稳定占 80 % ,右上腹部疼痛缓解 3例 ,减轻 4例 ,无好转 2例 ,未发现 度以上不良反应。结论　亚砷酸注射液单药治疗中晚期原发性肝癌 ,尤其是对初治者有一定疗效 ,在稳定生存质量及改善临床症状也有较好效果 ,毒副作用小。提示亚砷酸注射液可能会成为一种新的治疗肝癌和辅助治疗肝癌的药物更多还原

【Abstract】 Objective To study the short period effect and the side effects of Injectio arsenous acid when used to treat middle or advanced primary liver cancers.Methods From February 2001 to October 2001,10 cases of middle or advanced primary liver cancers were infused only with Injectio arsenous acid for 28 days.Results 80 per cent of the cases had stable life quality;3 cases right superior abdominal pain remission;4 cases relief and 2 cases no improvement.There was no Ⅲ degree or more severe side effects found.Conclusions Only using Injectio arsenous acid to treat middle or advanced liver cancer might be effective,especially for the initial treament.The stabilization of life quality,the improvement of clinical symptom and little side effects suggested that Injectio arsenous acid become a new drug or a new adjuvant for liver cancer.更多还原